Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 125 of the 132 references it cites were found in a registry or an index; 175 of the 298 sources its claims cite were checked for support.

Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review

Open access

Abstract

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder impacting women’s health and quality of life. This scoping review explores the use of the Internet of Things (IoT) in PCOS management. Results were grouped into six domains of the IoT: mobile apps, social media, wearables, machine learning, websites, and phone-based. A further domain was created to capture participants’ perspectives on using the IoT in PCOS management. Mobile apps appear to be useful for menstrual cycle tracking, symptom recording, and education. Despite concerns regarding the quality and reliability of social media content, these platforms may play an important role in disseminating PCOS-related information. Wearables facilitate detailed symptom monitoring and improve communication with healthcare providers. Machine learning algorithms show promising results in PCOS diagnosis accuracy, risk prediction, and app development. Although abundant, PCOS-related content on websites may lack quality and cultural considerations. While patients express concerns about online misinformation, they consider online forums valuable for peer connection. Using text messages and phone calls to provide feedback and support to PCOS patients may help them improve lifestyle behaviors and self-management skills. Advancing evidence-based, culturally sensitive, and accessible IoT solutions can enhance their potential to transform PCOS care, address misinformation, and empower women to better manage their symptoms.

Overview

CoChat Summary

TL;DR

This scoping review maps Internet of Things (IoT) use in polycystic ovary syndrome (PCOS) across mobile apps, social media, wearables, machine learning, websites, phone-based tools, and participant perspectives. It finds promise for tracking, education, diagnosis support, and peer support, but persistent concerns about misinformation, content quality, commercial bias, and cultural/access gaps.

Key findings

  • The review included 64 publications grouped into 59 eligible studies, with domains of mobile apps (n = 18), social media (n = 12), wearables (n = 11), machine learning (n = 10), websites (n = 8), and mobile phones (n = 6); nine qualitative studies captured participant voices. Most studies (n = 42) were published since 2020, including 23 in 2023.
  • Mobile apps were used for menstrual cycle tracking, symptom recording, and education: in an AskPCOS survey (n = 264), 86% would be more likely to use an app than a website (14%), 91% would use a PCOS-specific app, and important features included evidence-based information (95%), symptom recording (95%), and asking an expert (86%). One randomized trial reported 4.4% weight loss (75.84 to 72.65 kg) after 12 weeks versus 1.1% (72.98 to 72.19 kg) in the control group, with improvements in postprandial insulin, hirsutism, and depression.
  • Social media reached large audiences but carried misinformation and commercial conflicts: PCOS-related TikTok content averaged 1.8 million views, and conflict of interest was present in 45% of TikTok and 89% of Instagram posts. In 85,872 YouTube comments over 12 years, where gender was identifiable (n = 13,106), 88.5% (n = 11,601) were posted by female users; misinformation about a PCOS “cure” was the key theme among male comments (n = 1506, 11.5%).
  • Machine learning showed diagnostic promise but variable validation: reported accuracy ranged from 81% to 100%, with patient-data studies reporting 90.44%, 92.45%, and 98.41%; a systematic review of 31 studies found ultrasound images used in 48% and only 32% (n = 10) used standardized PCOS diagnostic criteria. Wearables found sleep-disordered breathing in 87.5% vs. 45.5% and lower sleep efficiency (82.8 ± 4.7 vs. 85.6 ± 4.3); an increment of 2000 steps/day was independently associated with decreased free androgen index. Websites often lacked quality: in a 2010 study of 15 websites, only two correctly described PCOS diagnostic criteria, and later studies noted commercial backgrounds and suboptimal accuracy.

Methods

  • Scoping review following Arksey and O’Malley and Levac et al., with updated Joanna Briggs Institute guidance and PRISMA-ScR reporting; the PCC question asked what and how the IoT is used in the management of women with PCOS.
  • Searches in Medline and IEEE were completed in December 2023, with no time or language limits for peer-reviewed full-text articles; inclusion covered IoT for or by people of any age diagnosed with PCOS, and exclusion covered studies without PCOS or without IoT use/evaluation.
  • Screening was done independently by SG, FA, and CK, with disagreements resolved by SG and CK and full texts screened by SG; data charting used a standardized form, descriptive analysis, frequency counting, and basic coding for qualitative studies. Database searches returned 219 studies, 2 duplicates, 217 screened, 145 excluded, 72 full texts retrieved, 8 excluded, leaving 64 publications grouped into 59 studies.

Limitations

  • The authors state that database selection and search strategy may have inadvertently omitted relevant literature; cultural aspects affecting digital literacy, acceptance, access, and technology use, plus local internet availability, may affect heterogeneity and generalizability; and subjectivity in synthesizing qualitative findings plus the absence of formal quality assessment (risk of bias and certainty of evidence) require cautious interpretation.
  • Evident from the text: the included evidence is heterogeneous across content analyses, surveys, trials, and modeling studies, and some samples are not restricted to PCOS—for example, the Flo chatbot sample of 416,712 users is described as an international sample where the majority do not have PCOS.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/healthcare12161671

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 PRISMA Flow diagram of database searches and study screening.
Figure 1 PRISMA Flow diagram of database searches and study screening.CC BY · PubMed Central
Figure 2 Summary of results: PCOS and the IoT (n = 64, nine studies mentioned multiple domains of the IoT).
Figure 2 Summary of results: PCOS and the IoT (n = 64, nine studies mentioned multiple domains of the IoT).CC BY · PubMed Central

Verification

Claims the paper makes

102 Valid · 2 Not valid · 37 Not checked · 39 Own results and interpretations

50 more claims · 30 with their cited sources checked

Create a free account to see all 180 claims and to verify the 9 references still open.

See all claims — free account
  • It may state two separate claims as one. 83
  • Probably not a substantial claim. 60
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 132 references

Cited by

See all 14

Metadata

Authors
Graca, S., Alloh, F., Lagojda, L., Dallaway, A., Kyrou, I., Randeva, H. S., & Kite, C.
Affiliations
  • University of Wolverhampton (GB)
  • University Hospital Coventry (GB)
  • Agricultural University of Athens (GR)
Corresponding author
  • Randeva, Harpal S.
  • Kite, Chris
Venue
Healthcare
Publisher
MDPI AG
Published
2024-08-21
Volume
12
Issue
16
Pages
1671
ISSN
2227-9032 (ISSN-L)
OpenAlex
W4401763477
Cited by
14
References
132
Citations by year
2026: 8 · 2025: 6
FWCI
1.25
Type
journal article
Language
en
Open access
Locations
  • Healthcare (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Bournemouth University Research Online (Bournemouth University) (acceptedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Pure (Coventry University) (acceptedVersion, cc-by)
  • ChesterRep (University of Chester) (submittedVersion, cc-by)
  • Wolverhampton Intellectual Repository and E-Theses (University of Wolverhampton) (submittedVersion)
Funders
  • University of Wolverhampton
  • University Hospitals Coventry and Warwickshire NHS Trust
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Social Sciences › Health › Social Media in Health Education
Keywords
polycystic ovary syndrome, Internet of Things, mobile health apps, social media, wearable devices, machine learning, PCOS diagnosis, online health misinformation, peer support, patient self-management, menstrual cycle tracking, patient perspectives

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review. https://app.cochat.ai/papers/10.3390/healthcare12161671
The paper
Graca, S., Alloh, F., Lagojda, L., Dallaway, A., Kyrou, I., Randeva, H. S., & Kite, C. (2024). Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review. Healthcare. https://doi.org/10.3390/healthcare12161671

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.